Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Explicit 15-minute arrival-time messages to help patients arrive on time

Official title: Arrival Time Implementation

Run by University of California, Los Angeles · NCT07314697 · Data updated 2026-11-12

This project will test whether showing an explicit arrival time (15 minutes before the scheduled appointment) in MyChart and automated texts helps primary care patients arrive on time for in-person visits.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300000 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedFebruary 10, 2026
Trial IDNCT07314697 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with in-person primary care, pediatrics, or internal medicine appointments at UCLA Health who have an active MyChart account, are opted into SMS messages, and are scheduled for the specified visit types.

Probably not a fit

Patients without MyChart or SMS access, those scheduled at clinics not managed through UCLA's Patient Access Organization, and telehealth visits are unlikely to experience benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Timely patient arrival is essential for efficient clinic flow and to ensure patients receive their full scheduled care. This prospective interventional project changes how appointment information is presented in MyChart and automated text messages, comparing explicit arrival-time messaging (set 15 minutes before the appointment) to the usual display of appointment time plus an instruction to arrive 15 minutes early. The work is implemented across outpatient primary care, pediatrics, and internal medicine departments at UCLA Health as part of a broader operational quality improvement initiative. Arrival timing for scheduled visits will be measured and compared between the intervention and control messaging conditions to determine the effect on punctuality.

Why it matters

Potential benefit: If successful, this low-cost messaging change could increase on-time arrivals, reduce clinic delays, and preserve more face-to-face time with clinicians.

How similar studies have gone: Prior behavioral-message and reminder interventions have improved clinic attendance and punctuality, though explicit 'arrival time' framing is a somewhat novel application within that evidence base.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* In-person outpatient appointments with clinicians at UCLA Health that fall into the study period
* Appointments scheduled for the department specialties of Primary Care, Pediatrics, or Internal Medicine, Med Peds
* Has an active MyChart status
* Opted in to receive SMS communications from UCLA Health
* Appointments classified as the following visit types:

  * Return
  * Well adult (physical)
  * Well child return
  * New
  * Well adult new (physical)
  * Well child (new)

Exclusion Criteria:

* Appointments at clinics that are not scheduled through the Patient Access Organization

Where it's running

  • UCLA Health Department of Medicine, Quality Office
    Los Angeles, California, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.